(MedPage Today) — Three drugs that inhibit the immunoglobulin G (IgG) neonatal fragment crystallizable receptor (FcRn) were approved to treat generalized myasthenia gravis (MG) in recent years: efgartigimod (Vyvgart), rozanolixizumab (Rystiggo…
Source link : https://www.medpagetoday.com/spotlight/gmg/119911
Author :
Publish date : 2026-02-17 18:18:00
Copyright for syndicated content belongs to the linked Source.
